Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study.

Authors :: Thatcher N
Goldschmidt JH
Thomas M
Schenker M
Pan Z
Rodriguez LP
Breder V
Ostoros G
Hanes V
Source :: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 May 15; Vol. 25 (10), pp. 3193.
Publication Year :: 2019

Language :: English
ISSN :: 1557-3265
Volume :: 25
Issue :: 10
Database :: MEDLINE
Journal :: Clinical cancer research : an official journal of the American Association for Cancer Research
Publication Type :: Academic Journal
Accession number :: 31092617
Full Text :: https://doi.org/10.1158/1078-0432.CCR-19-1098

Full Text Access

Tools